Juan Chen
Pudong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA-340/SENP6/SUMOylation Pathway.
Journal: The journal of gene medicine
Published: September 23, 2025
Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
Journal: The journal of gene medicine
Published: April 07, 2023
Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways.
Journal: Journal of Cancer
Published: February 09, 2023
Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1/lipoic acid pathway activation.
Journal: Journal of Cancer
Published: July 25, 2022
Superparamagnetic Iron Oxide Nanoparticles Induce Ferroptosis of Human Ovarian Cancer Stem Cells by Weakening Cellular Autophagy.
Journal: Journal of biomedical nanotechnology
Published: January 19, 2021
DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.
Journal: Journal of cellular and molecular medicine
Published: December 20, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026